John Lunger - 03 Mar 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
Director
Signature
/s/ Diantha Duvall, Attorney-in-Fact for John Lunger
Issuer symbol
N/A
Transactions as of
03 Mar 2022
Net transactions value
$0
Form type
4
Filing time
07 Mar 2022, 17:14:28 UTC
Previous filing
18 Jan 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNCA Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 03 Mar 2022 Common Stock 30,000 $1.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are scheduled to vest in 36 equal monthly installments beginning on the first monthly anniversary of the grant date.